Buy Bijuve Capsules Online in the UK
A brand-new oral HRT tablet called Bijuve was introduced in September 2021.
The tablet, created for women who have an intact womb (i.e., who have not had a hysterectomy) and whose last menstruation was at least a year ago, contains 1 mg of oestradiol (oestrogen) and 100 mg of progesterone.
Because they are "body identical," or chemically and biologically the same as hormones that naturally circulate in a woman's body, oestradiol and progesterone are both safe for use.
What distinguishes Bijuve from other HRT?
A synthetic progestogen is present in every other HRT tablet that contains both oestrogen and progestogen. The oestrogen and progestogen in Bijuve are "body identical" hormones, meaning they are biochemically identical to the hormones your body produces.
Two hormones, an oestrogen and a progestogen are used in HRT. In most cases, only the oestrogen component is required if you've undergone a hysterectomy. Body-identical oestradiol makes up the vast bulk of prescription oestrogen. Tibolone and those containing Premarin are the exceptions. Equine oestrogen conjugates are present in Premarin formulations (i.e., a mix of oestrogen derived from horse urine). Tibolone has oestrogen, progestogen, and androgen (male hormone)-like characteristics and is entirely synthetic.
What benefits can body-identical hormones offer?
In comparison to synthetic alternatives, body-identical progesterone has a decreased risk of breast cancer and has no influence on blood coagulation or blood lipids like cholesterol.
This is a suitable alternative for you if you take separate estradiol 1mg tablets and Utrogestan 100mg capsules daily.
Progesterone has a utero-protective function and so must be taken if you are peri-menopausal or post-menopausal and have not had a hysterectomy.
Bijuve (Estradiol) 1mg Capsules reviews
How to use Bijuve (Estradiol) 1mg Capsules
One Capsule daily continuously - take every evening with or after food.
Side effects of Bijuve (Estradiol) 1mg Capsules
Always read the package leaflet before use.
Do not take Bijuve if:
- If you have cancer which is sensitive to oestrogens, such as cancer of the womb lining (endometrium), or if you are suspected of having it
- if you are allergic to estradiol hemihydrate or progesterone or any of the other ingredients of this medicine
- If you have or recently have had a disease caused by blood clots in the arteries, such as a heart attack, stroke or angina
- If you have or have ever had breast cancer, or if you are suspected of having it
- If you have any unexplained vaginal bleeding
- If you have or have ever had a liver disease and your liver function tests have not returned to normal
- If you have a rare blood problem called “porphyria” which is passed down in families (inherited)
- If you have excessive thickening of the womb lining (endometrial hyperplasia) that is not being treated
- If you have or have ever had a blood clot in a vein (thrombosis), such as in the legs (deep venous thrombosis) or the lungs (pulmonary embolism)
- If you have a blood clotting disorder (such as protein C, protein S, or antithrombin deficiency)
If any of the above issues emerge for the first time while using Bijuve, stop using it right once and call your doctor.
Bijuve side effects:
Breast tenderness, headache, nausea, pelvic pain, vaginal discharge, and irregular vaginal bleeding are the most typical side effects, which are similar to those of other types of HRT.
Keep out of the reach and sight of children.
Keep the blister in the outer carton in order to protect it from light.
Do not store in the fridge or freezer.